These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36611127)

  • 21. SASDAS (simplified version of ankylosing spondylitis disease activity score)-ESR performance and development of SASDAS-CRP and their agreement with ASDAS-ESR and ASDAS-CRP in patients with ankylosing spondylitis.
    Schneeberger EE; Zamora N; Citera G
    Clin Rheumatol; 2016 Nov; 35(11):2865-2866. PubMed ID: 27357718
    [No Abstract]   [Full Text] [Related]  

  • 22. Performance of the Ankylosing Spondylitis Disease Activity Score based on a quick quantitative C-reactive protein assay in patients with axial spondyloarthritis.
    Proft F; Muche B; Spiller L; Rios Rodriguez V; Rademacher J; Weber AK; Lüders S; Protopopov M; Redeker I; Spiller I; Sieper J; Poddubnyy D
    Joint Bone Spine; 2020 Jan; 87(1):69-73. PubMed ID: 31369867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
    Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
    Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease activity assessment in ankylosing spondylitis in a Chinese cohort: BASDAI or ASDAS?
    Au YL; Wong WS; Mok MY; Chung HY; Chan E; Lau CS
    Clin Rheumatol; 2014 Aug; 33(8):1127-34. PubMed ID: 24981160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal Association Between Trabecular Bone Loss and Disease Activity in Axial Spondyloarthritis: A 4-year Prospective Study.
    Kang KY; Ju JH; Park SH; Hong YS
    J Rheumatol; 2020 Sep; 47(9):1330-1337. PubMed ID: 31732556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simplified version of Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with ankylosing spondylitis.
    Sommerfleck FA; Schneeberger EE; Buschiazzo EE; Maldonado Cocco JA; Citera G
    Clin Rheumatol; 2012 Nov; 31(11):1599-603. PubMed ID: 22895877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bath Ankylosing Spondylitis Disease Activity Index is Associated With the Quality of Sleep in Ankylosing Spondylitis Patients.
    Song BW; Jeong HJ; Kim BY; Cho YW; Son CN; Kim SS; Kim SH
    J Rheum Dis; 2021 Jul; 28(3):143-149. PubMed ID: 37475993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The value of ankylosing spondylitis disease activity score in evaluating disease activity of ankylosing spondylitis].
    DU XN; Li Y; Zhang SL; Zhu J; Huang F
    Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):206-9. PubMed ID: 22781894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care.
    Park SH; Choe JY; Kim SK; Lee H; Castrejón I; Pincus T
    J Clin Rheumatol; 2015 Sep; 21(6):300-4. PubMed ID: 26308349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Scoring of disease activity using BASDAI and ASDAS method in ankylosing spondylitis].
    Bobek D; Zagar I; Kovač-Durmiš K; Perić P; Ćurković B; Babić-Naglić Ð
    Reumatizam; 2012; 59(1):5-10. PubMed ID: 25486721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.
    Lukas C; Landewé R; Sieper J; Dougados M; Davis J; Braun J; van der Linden S; van der Heijde D;
    Ann Rheum Dis; 2009 Jan; 68(1):18-24. PubMed ID: 18625618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of clinical manifestations according to HLA-B(27) genotype in ankylosing spondylitis patients: real-world evidence from smart management system for spondyloarthritis].
    Ji XJ; Sun K; Hu ZY; Zhang Y; Ma YP; Sun Z; Li KP; Zhu J; Zhang JL; Huang F
    Zhonghua Nei Ke Za Zhi; 2018 Mar; 57(3):179-184. PubMed ID: 29518861
    [No Abstract]   [Full Text] [Related]  

  • 33. Calculating the ankylosing spondylitis disease activity score if the conventional c-reactive protein level is below the limit of detection or if high-sensitivity c-reactive protein is used: an analysis in the DESIR cohort.
    Machado P; Navarro-Compán V; Landewé R; van Gaalen FA; Roux C; van der Heijde D
    Arthritis Rheumatol; 2015 Feb; 67(2):408-13. PubMed ID: 25332195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.
    Mermerci Başkan B; Pekin Doğan Y; Sivas F; Bodur H; Ozoran K
    Rheumatol Int; 2010 Jan; 30(3):375-81. PubMed ID: 19685057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The value of erythrocyte sedimentation rate and C-reactive protein in evaluating disease activity in ankylosing spondylitis].
    Liu B; Guo CY; Liu WQ; Wu N; Xing Q
    Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):566-9. PubMed ID: 16194404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Relationship between Plasma Pentraxin 3 and Serum Amyloid P Levels and Disease Activity in Ankylosing Spondylitis.
    Özdemirel AE; Güven SC; Sunar İ; Sari Sürmeli Z; Doğanci A; Tutkak H; Yalçin Sayin AP; Ataman Ş
    Int J Clin Pract; 2022; 2022():7243399. PubMed ID: 35685583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis: the product of these acute-phase reactants and disease duration is associated with patient's poor physical mobility.
    Chen CH; Chen HA; Liao HT; Liu CH; Tsai CY; Chou CT
    Rheumatol Int; 2015 Jul; 35(7):1263-7. PubMed ID: 25708781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
    Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
    J Rheumatol; 1999 Apr; 26(4):980-4. PubMed ID: 10229432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers.
    Gentileschi S; Vitale A; Rigante D; Lopalco G; Emmi G; Orlando I; Di Scala G; Sota J; Fabiani C; Frediani B; Galeazzi M; Lapadula G; Iannone F; Cantarini L
    Isr Med Assoc J; 2018 Jul; 20(7):438-441. PubMed ID: 30109794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis.
    Chen YH; Huang WN; Chen YM; Lai KL; Hsieh TY; Hung WT; Lin CT; Tseng CW; Tang KT; Chou YY; Wu YD; Huang CY; Hsieh CW; Chen YJ; Liao YW; Chen HH
    Front Med (Lausanne); 2022; 9():856654. PubMed ID: 35652077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.